PMID- 32340315 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20200928 IS - 2077-0383 (Print) IS - 2077-0383 (Electronic) IS - 2077-0383 (Linking) VI - 9 IP - 4 DP - 2020 Apr 23 TI - The Effects of Granulocyte Colony-Stimulating Factor in Patients with a Large Anterior Wall Acute Myocardial Infarction to Prevent Left Ventricular Remodeling: A 10-Year Follow-Up of the RIGENERA Study. LID - 10.3390/jcm9041214 [doi] LID - 1214 AB - BACKGROUND: the RIGENERA trial assessed the efficacy of granulocyte-colony stimulating factor (G-CSF) in the improvement of clinical outcomes in patients with severe acute myocardial infarction. However, there is no evidence available regarding the long-term safety and efficacy of this treatment. METHODS: in order to evaluate the long-term effects on the incidence of major adverse events, on the symptom burden, on the quality of life and the mean life expectancy and on the left ventricular (LV) function, we performed a clinical and echocardiographic evaluation together with an assessment using the Minnesota Living with Heart Failure Questionnaire (MLHFQ) and the Seattle Heart Failure Model (SHFM) at 10-years follow-up, in the patients cohorts enrolled in the RIGENERA trial. RESULTS: thirty-two patients were eligible for the prospective clinical and echocardiography analyses. A significant reduction in adverse LV remodeling was observed in G-CSF group compared to controls, 9% vs. 48% (p = 0.030). The New York Heart Association (NYHA) functional class was lower in G-CSF group vs. controls (p = 0.040), with lower burden of symptoms and higher quality of life (p = 0.049). The mean life expectancy was significantly higher in G-CSF group compared to controls (15 +/- 4 years vs. 12 +/- 4 years, p = 0.046. No difference was found in the incidence of major adverse events. CONCLUSIONS: this longest available follow-up on G-CSF treatment in patients with severe acute myocardial infarction (AMI) showed that this treatment was safe and associated with a reduction of adverse LV remodeling and higher quality of life, in comparison with standard-of-care treatment. FAU - Leone, Antonio Maria AU - Leone AM AUID- ORCID: 0000-0002-1276-9883 AD - Department of Cardiovascular Sciences, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Universita Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy. FAU - D'Amario, Domenico AU - D'Amario D AD - Department of Cardiovascular Sciences, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Universita Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy. FAU - Cannata, Francesco AU - Cannata F AD - Universita Cattolica del Sacro Cuore, 00168 Rome, Italy. FAU - Graziani, Francesca AU - Graziani F AUID- ORCID: 0000-0002-4520-5689 AD - Department of Cardiovascular Sciences, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Universita Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy. FAU - Borovac, Josip A AU - Borovac JA AUID- ORCID: 0000-0002-4878-8146 AD - Universita Cattolica del Sacro Cuore, 00168 Rome, Italy. FAU - Leone, Giuseppe AU - Leone G AD - Universita Cattolica del Sacro Cuore, 00168 Rome, Italy. FAU - De Stefano, Valerio AU - De Stefano V AD - Universita Cattolica del Sacro Cuore, 00168 Rome, Italy. FAU - Basile, Eloisa AU - Basile E AD - Universita Cattolica del Sacro Cuore, 00168 Rome, Italy. FAU - Siracusano, Andrea AU - Siracusano A AD - Universita Cattolica del Sacro Cuore, 00168 Rome, Italy. FAU - Galiuto, Leonarda AU - Galiuto L AD - Universita Cattolica del Sacro Cuore, 00168 Rome, Italy. FAU - Locorotondo, Gabriella AU - Locorotondo G AD - Department of Cardiovascular Sciences, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Universita Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy. FAU - Porto, Italo AU - Porto I AD - Department of Cardiovascular Sciences, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Universita Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy. FAU - Vergallo, Rocco AU - Vergallo R AD - Universita Cattolica del Sacro Cuore, 00168 Rome, Italy. FAU - Canonico, Francesco AU - Canonico F AUID- ORCID: 0000-0001-6936-4548 AD - Universita Cattolica del Sacro Cuore, 00168 Rome, Italy. FAU - Restivo, Attilio AU - Restivo A AD - Universita Cattolica del Sacro Cuore, 00168 Rome, Italy. FAU - Rebuzzi, Antonio Giuseppe AU - Rebuzzi AG AD - Universita Cattolica del Sacro Cuore, 00168 Rome, Italy. FAU - Crea, Filippo AU - Crea F AD - Universita Cattolica del Sacro Cuore, 00168 Rome, Italy. LA - eng GR - MIUR- PRIN 2010/Ministero dell'Istruzione, dell'Universita e della Ricerca/ GR - unrestricted grant/Banca d'Italia/ PT - Journal Article DEP - 20200423 PL - Switzerland TA - J Clin Med JT - Journal of clinical medicine JID - 101606588 PMC - PMC7230316 OTO - NOTNLM OT - G-CSF OT - granulocyte colony-stimulating factor OT - left ventricular remodeling OT - long-term effects OT - myocardial infarction OT - quality of life COIS- A.M.L. received speaking honoraria from Bracco Imaging. The other authors have no conflict of interest to disclose. EDAT- 2020/04/29 06:00 MHDA- 2020/04/29 06:01 PMCR- 2020/04/23 CRDT- 2020/04/29 06:00 PHST- 2020/03/29 00:00 [received] PHST- 2020/04/18 00:00 [revised] PHST- 2020/04/20 00:00 [accepted] PHST- 2020/04/29 06:00 [entrez] PHST- 2020/04/29 06:00 [pubmed] PHST- 2020/04/29 06:01 [medline] PHST- 2020/04/23 00:00 [pmc-release] AID - jcm9041214 [pii] AID - jcm-09-01214 [pii] AID - 10.3390/jcm9041214 [doi] PST - epublish SO - J Clin Med. 2020 Apr 23;9(4):1214. doi: 10.3390/jcm9041214.